NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Cian Healthcare

BSE: 542678 21 Feb 2025
Healthcare
₹ 3.94
Cian Healthcare Limited specializes in Pharmaceuticals within the Healthcare sector.

Cian Healthcare - Share Price & Details

Market Cap
₹9.84
High /Low
26.5 / 2.97
Stock P/E
39.4
Book Value
₹23.1
Dividend Yield
0.0
ROCE
5.22
ROE
₹0.43
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹5.59
Debt
55.7
CMP / FCF
1.6
Debt to equity
₹0.96
NP Ann
0.25
High price all time
62.5
Piotroski score
₹6.0
Graham Number
7.21
No. Eq. Shares
2.5
Net CF
₹-0.14
Net profit
0.25
Price to book value
0.17
Interest Coverage
₹1.01
Low price all time
2.97
Industry PE
29.9
Reserves
₹32.7
Free Cash Flow
₹10.8

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
Cian Healthcare LimitedNANA39.4
Checkpoint Trends Limited1.00-0.01
Satiate Agri LimitedNA1.93

Peer Comparison Chart


About Cian Healthcare

Cian Healthcare Limited, with Security Code 542678, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

MPS Pharmaa Share Price

(23 Dec 2024)
What's MPS Pharmaa Ltd share price today. Get MPS Pharmaa Ltd latest news on BSE/NSE stock price live updates, MPS Pharmaa Ltd financial...
Read more →

aciana Unveils the Cian Healthcare Ecosystem: Revolutionizing Healthcare in Bharat with AI and Genetics

(19 Dec 2024)
aciana envisions a future where healthcare is not one-size-fits-all but instead tailored to each individual's unique needs, powered by their...
Read more →

aciana Unveils the Ciana Healthcare Ecosystem: Revolutionizing Healthcare in Bharat with AI and Genetics

(19 Dec 2024)
aciana envisions a future where healthcare is not one-size-fits-all but instead tailored to each individual's unique needs, powered by their...
Read more →

Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel

(04 Dec 2024)
New Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi...
Read more →

Dyslexia Treatment Market Advancements Highlighted by Share, Growth, Demand, Trends, Opportunities And Outl...

(21 Nov 2024)
Global dyslexia treatment market size is expected to reach $37.06 Bn by 2028 at a rate of 7.1%, segmented as by type, double deficit...
Read more →

Dyslexia Treatment Market Future Business Opportunities

(15 Nov 2024)
Press release - Coherent Market Insights - Dyslexia Treatment Market Future Business Opportunities 2024-2031 | Pfizer, Inc.,...
Read more →